Fake COVID-19 vaccinations in Africa

Deliveries of vaccine supplies by the COVAX programme under the WHO commenced in February 2021.1 COVAX has proposed to distribute 520 million doses to Africa by the end of 2021.1 On 28 March 2021, African Union member states endorsed purchasing 220 million doses of the Johnson & Johnson single shot of the COVID-19 vaccine. However, priority was given to the Johnson & Johnson vaccine to the central-most pooled procurement due to being a single-shot vaccine, being cheap and easy to administer, having good storage conditions and production of doses being within Africa, with fill–finish activities taking place in South Africa.2 Moreover, greater than half of the vaccine doses received so far in Africa have been through either direct purchases or donations. Countries such as Burundi and Eritrea are yet to receive vaccines. Burundi has expressed a willingness to receive the vaccines but states...

Source: Postgraduate Medical Journal - April 21, 2022 Category: General Medicine Authors: Aborode, A. T., Awuah, W. A., Talukder, S., Oyeyemi, A. A., Nansubuga, E. P., Machai, P., Tillewein, H., Oko, C. I. Tags: COVID-19 Editorials Source Type: research